Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.35% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.62% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2751
Bitdeer Technologies
BTDR
$1.63B
| $1.26M | ﹤0.01% |
79,143
+4,403
| +6% | +$63.2K |
2023 Q3
11 quarters
|
|
2752
GCM Grosvenor
GCMG
$774M
| $1.25M | ﹤0.01% |
101,242
+3,304
| +3% | +$36.1K |
2021 Q3
19 quarters
|
|
2753
Procept Biorobotics
PRCT
$1.19B
| $1.25M | ﹤0.01% |
55,146
+791
| +1% | +$19.8K |
2022 Q2
16 quarters
|
|
2754
CNB Financial Corp
CCNE
$1.06B
| $1.24M | ﹤0.01% |
36,916
+185
| +0.5% | +$5.76K |
2021 Q1
21 quarters
|
|
2755
Willis Lease Finance
WLFC
$992M
| $1.24M | ﹤0.01% |
16,308
-249
| -2% | -$16.3K |
2024 Q4
6 quarters
|
|
2756
Atea Pharmaceuticals
AVIR
$346M
| $1.24M | ﹤0.01% |
267,125
+133,777
| +100% | +$665K |
2021 Q1
21 quarters
|
|
2757
Peapack-Gladstone Financial
PGC
$814M
| $1.24M | ﹤0.01% |
26,213
-1,401
| -5% | -$59.2K |
2014 Q1
49 quarters
|
|
2758
Financial Institutions
FISI
$776M
| $1.24M | ﹤0.01% |
31,793
-2,244
| -7% | -$79.7K |
2013 Q2
52 quarters
|
|
2759
Savara
SVRA
$992M
| $1.24M | ﹤0.01% |
200,685
-22,325
| -10% | -$120K |
2023 Q2
12 quarters
|
|
2760
IMAX
IMAX
$2.61B
| $1.23M | ﹤0.01% |
30,807
-336,924
| -92% | -$12.9M |
2015 Q1
45 quarters
|
|
2761
Emergent Biosolutions
EBS
$312M
| $1.22M | ﹤0.01% |
146,065
-36,390
| -20% | -$304K |
2013 Q2
52 quarters
|
|
2762
Lexicon Pharmaceuticals
LXRX
$793M
| $1.22M | ﹤0.01% |
508,071
-4,355
| -0.8% | -$8.48K |
2020 Q2
24 quarters
|
|
2763
Liberty All-Star Equity Fund
USA
$1.84B
| $1.22M | ﹤0.01% |
209,862
-104,120
| -33% | -$601K |
2013 Q2
52 quarters
|
|
2764
Western Asset Premier Bond Fund
WEA
$116M
| $1.22M | ﹤0.01% |
114,442
-2,884
| -2% | -$30.6K |
2013 Q2
52 quarters
|
|
2765
Limbach Holdings
LMB
$627M
| $1.21M | ﹤0.01% |
15,738
+1,994
| +15% | +$166K |
2023 Q1
13 quarters
|
|
2766
Central Bancompany Inc
CBC
$9.04B
| $1.21M | ﹤0.01% |
39,783
+2,535
| +7% | +$68.9K |
2026 Q1
1 quarter
|
|
2767
Eton Pharmaceutcials
ETON
$1.63B
| $1.21M | ﹤0.01% |
33,384
+10,510
| +46% | +$308K |
2025 Q2
4 quarters
|
|
2768
Arbutus Biopharma
ABUS
$723M
| $1.2M | ﹤0.01% |
250,907
+2,982
| +1% | +$13.1K |
2021 Q2
20 quarters
|
|
2769
Phreesia
PHR
$783M
| $1.2M | ﹤0.01% |
116,605
+14,808
| +15% | +$138K |
2019 Q4
26 quarters
|
|
2770
Asana
ASAN
$2.43B
| $1.19M | ﹤0.01% |
169,358
+37,269
| +28% | +$250K |
2021 Q2
20 quarters
|
|
2771
Webull Corp
BULL
$2.66B
| $1.18M | ﹤0.01% |
181,326
-111,698
| -38% | -$723K |
2025 Q4
2 quarters
|
|
2772
Mesa Laboratories
MLAB
$718M
| $1.18M | ﹤0.01% |
11,862
-2,241
| -16% | -$226K |
2018 Q1
33 quarters
|
|
2773
Riley Exploration Permian
REPX
$912M
| $1.18M | ﹤0.01% |
35,740
+1,463
| +4% | +$52.2K |
2025 Q1
5 quarters
|
|
2774
Nextdoor Holdings, Inc. Class A Common Stock
NXDR
$758M
| $1.18M | ﹤0.01% |
518,810
+50,097
| +11% | +$93.5K |
2023 Q2
12 quarters
|
|
2775
Xerox
XRX
$143M
| $1.17M | ﹤0.01% |
374,942
-84,929
| -18% | -$212K |
2013 Q2
52 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.